DENTONE, CHIARA
 Distribuzione geografica
Continente #
EU - Europa 9.408
AS - Asia 1.273
NA - Nord America 616
SA - Sud America 120
AF - Africa 30
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 11.450
Nazione #
IT - Italia 9.175
US - Stati Uniti d'America 574
SG - Singapore 544
CN - Cina 293
VN - Vietnam 271
BR - Brasile 76
FR - Francia 74
FI - Finlandia 45
HK - Hong Kong 41
DE - Germania 31
MX - Messico 19
AR - Argentina 18
GB - Regno Unito 17
BD - Bangladesh 16
JP - Giappone 15
NL - Olanda 14
IN - India 13
CA - Canada 12
IQ - Iraq 12
PK - Pakistan 10
ZA - Sudafrica 10
ID - Indonesia 9
PH - Filippine 8
EC - Ecuador 7
ES - Italia 7
UA - Ucraina 7
CH - Svizzera 6
RU - Federazione Russa 6
TH - Thailandia 6
TR - Turchia 6
AE - Emirati Arabi Uniti 5
VE - Venezuela 5
CL - Cile 4
CO - Colombia 4
DZ - Algeria 4
NP - Nepal 4
PT - Portogallo 4
PY - Paraguay 4
SE - Svezia 4
DO - Repubblica Dominicana 3
EG - Egitto 3
ET - Etiopia 3
GR - Grecia 3
KE - Kenya 3
KR - Corea 3
TN - Tunisia 3
AT - Austria 2
AU - Australia 2
AZ - Azerbaigian 2
CR - Costa Rica 2
HN - Honduras 2
HR - Croazia 2
HU - Ungheria 2
IR - Iran 2
JO - Giordania 2
SA - Arabia Saudita 2
TW - Taiwan 2
UZ - Uzbekistan 2
BE - Belgio 1
CZ - Repubblica Ceca 1
GA - Gabon 1
GE - Georgia 1
IE - Irlanda 1
KG - Kirghizistan 1
KY - Cayman, isole 1
LC - Santa Lucia 1
LT - Lituania 1
MA - Marocco 1
MD - Moldavia 1
MK - Macedonia 1
MT - Malta 1
MY - Malesia 1
NG - Nigeria 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
SV - El Salvador 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 11.450
Città #
Genoa 3.997
Genova 3.095
Rapallo 1.049
Vado Ligure 878
Singapore 272
San Jose 193
Ho Chi Minh City 84
Council Bluffs 75
Hanoi 70
Lauterbourg 64
Ashburn 55
Beijing 52
Helsinki 45
Hong Kong 41
Bordighera 39
Frankfurt am Main 24
New York 20
Rome 13
Santa Clara 13
São Paulo 12
Tokyo 12
Haiphong 9
Mexico City 9
Da Nang 8
Tianjin 8
Biên Hòa 7
City of London 7
Kyiv 7
Los Angeles 7
Milan 7
Johannesburg 6
Paris 6
Rio de Janeiro 6
Zurich 6
Atlanta 5
Hải Dương 5
Lahore 5
Piscataway 5
Toronto 5
Amsterdam 4
Bangkok 4
Bari 4
Buffalo 4
Bắc Giang 4
Denver 4
Madrid 4
Orem 4
Stockholm 4
Baghdad 3
Bắc Ninh 3
Cairo 3
Chicago 3
Houston 3
Jakarta 3
London 3
Manchester 3
Mosul 3
Nha Trang 3
Nuremberg 3
Quito 3
Santiago 3
Shanghai 3
Abu Dhabi 2
Addis Ababa 2
Amman 2
Ankara 2
Asunción 2
Athens 2
Baku 2
Baoding 2
Basingstoke 2
Birmingham 2
Boston 2
Brasília 2
Buenos Aires 2
Bình Phước 2
Campinas 2
Can Tho 2
Caracas 2
Cascina 2
Catania 2
Charlotte 2
Chengdu 2
Chennai 2
Curitiba 2
Duhok 2
Florence 2
Fortaleza 2
Guangzhou 2
Guayaquil 2
Ha Long 2
Hyderabad 2
Istanbul 2
Itaquaquecetuba 2
Kathmandu 2
Lisbon 2
Long Xuyen 2
Ninh Bình 2
North Bergen 2
Nova Iguaçu 2
Totale 10.375
Nome #
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 321
The Ligurian Human Immunodeficiency Virus Clinical Network: A Web Tool to Manage Patients With Human Immunodeficiency Virus in Primary Care and Multicenter Clinical Trials 242
Effectiveness, safety, durability and immune recovery in a retrospective, multicentre, observational cohort of ART-experienced, HIV-1-infected patients receiving maraviroc 232
Budget impact analysis of sofosbuvir-based regimens for the treatment of HIV/HCV-coinfected patients in northern Italy: A multicenter regional simulation 220
A Standard Interface for Data Reuse in Infectious Diseases 214
A Web based tool for antimicrobial resistance evaluation in immunocompromised patient 207
Budget Impact Analysis of Sofosbuvir-Based Regimens for The Treatment of Hiv/Hcv Co-Infected Patients In Northern Italy: The Liguria Region Simulation 206
A comparison of inpatient admissions in 2012 from two European countries 192
Bronchoalveolar lavage fluid characteristics and outcomes of invasively mechanically ventilated patients with COVID-19 pneumonia in Genoa, Italy 190
Cost per care of the first year of direct antiviral agents in the liguria region: A multicenter analysis 188
Ricoveri ospedalieri dei pazienti con infezione da HIV in Liguria: risultati preliminari dello studio ACTEA 188
Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19 188
Use of maraviroc in clinical practice: a multicenter observational study 186
Use of colistin in adult patients: a cross-sectional study 185
Multicentre Clinical Trials’ data management: A hybrid solution to exploit the strengths of Electronic Data Capture and Electronic Health Records systems 184
Rete Ligure dell’HIV: due anni di esperienza nella gestione del dato clinico 178
Inpatient admissions of patients living with HIV in two European centres (UK and Italy); comparisons and contrasts 177
Prevalence and Clinical Significance of Persistent Viral Shedding in Hospitalized Adult Patients with SARS-CoV-2 Infection: A Prospective Observational Study 174
Bloodstream infections in critically ill patients with COVID-19 171
Relationship between innate immunity, soluble markers and metabolic-clinical parameters in HIV+ patients ART treated with HIV-RNA < 50 cp/mL 167
Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk Factors 159
On-field evaluation of a ultra-rapid fluorescence immunoassay as a frontline test for SARS-CoV-2 diagnostic 158
Weight gain: A possible side effect of all antiretrovirals 153
External validation of unsupervised COVID-19 clinical phenotypes and their prognostic impact 152
From Liguria HIV Web to Liguria Infectious Diseases Network: How a Digital Platform Improved Doctors' Work and Patients' Care 150
Improvement of lipid profile after switching from efavirenz or ritonavir-boosted protease inhibitors to rilpivirine or once-daily integrase inhibitors: Results from a large observational cohort study (SCOLTA) 150
Tocilizumab and steroid treatment in patients with COVID-19 pneumonia 146
Web interaction to improve collaboration in monitoring of microbial infections 144
Control of the HIV-1 DNA reservoir is associated in vivo and in vitro with NKp46/NKp30 (CD335 CD337) inducibility and interferon gamma production by transcriptionally unique NK cells 144
Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity 141
Assessment of appropriateness of first-line combined antiretroviral treatment (cART): the preliminary results of Liguria experience V.E.L.A. study 140
Successful antiretroviral therapy by using unusual antiretroviral combinations in heavily pre-treated patients: two case reports 139
CD8+CD28-CD127loCD39+ T reg: a new biomarker for HIV infection 138
LiHlm-Web: a web-application in order to collect, share and analyze immunological data of HIV patients in multicentric studies 136
CD8+CD28-CD127loCD39+Treg Expansion: a New Pathogenic Mechanism for HIV Infection? 135
Early effects of ventilatory rescue therapies on systemic and cerebral oxygenation in mechanically ventilated COVID-19 patients with acute respiratory distress syndrome: a prospective observational study 128
Prevalence of acquired resistance mutations in a large cohort of perinatally infected HIV-1 patients 127
Reactivation of Herpes Simplex Virus Type 1 (HSV-1) Detected on Bronchoalveolar Lavage Fluid (BALF) Samples in Critically Ill COVID-19 Patients Undergoing Invasive Mechanical Ventilation: Preliminary Results from Two Italian Centers 127
Successful antiretroviral therapy by using unusual antiretroviral combinations in heavily pre-treated patients: two case reports 126
Genetic polymorphisms of IL28b gene as predictors of response to dual therapy in genotypes 1 and 4-HCV and HIV/HCV-infected patients 122
The impact of liver disease: a leading cause of hospital admissions in people living vith HIV 122
A very rare case of mycobacterium gordonae infection of the breast 122
Valutazione di parametri di immunità innata e di infiammazione correlati ad aspetti clinico-metabolici in una coorte di pazienti HIV positivi con carica virale non rilevabile 121
Lung distribution of gas and blood volume in critically ill COVID-19 patients: a quantitative dual-energy computed tomography study 120
Distinct features of immune activation and exhaustion markers in people with perinatally-acquired HIV 118
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study 115
Characterization of T lymphocytes in severe COVID-19 patients 115
Raltegravir-based therapy in a cohort of HIV/HCV co-infected individuals 114
Enterococcal bloodstream infections in critically ill patients with COVID-19: a case series 112
High-temporal resolution profiling reveals distinct immune trajectories following the first and second doses of COVID-19 mRNA vaccines 111
Muscle symptoms and creatine phosphokinase elevations in patients receiving raltegravir in clinical practice: Results from the SCOLTA project long-term surveillance 111
A comparative analysis of the first and second COVID-19 wave in Italy: evaluation of mortality in the Infectious Disease Unit of Genoa University Hospital 111
Use of ceftaroline in hospitalized patients with and without covid-19: A descriptive cross-sectional study 111
Utilizzo di Maraviroc nella pratica clinica: studio multicentrico osservazionale (MARHIV STUDY) 109
Early administration of bamlanivimab in combination with etesevimab increases the benefits of covid-19 treatment: Real-world experience from the liguria region 109
Aspergillus-PCR in bronchoalveolar lavage - diagnostic accuracy for invasive pulmonary aspergillosis in critically ill patients 104
T2Bacteria and T2Resistance Assays in Critically Ill Patients with Sepsis or Septic Shock: A Descriptive Experience 104
The Ligurian HIV network: How medical informatics standards can help clinical research 104
Effect of SARS-CoV-2 vaccination in a vulnerable COVID-19 cohort: a real-life experience in an Italian Hospital 103
HCMV-controlling NKG2C+ NK cells originate from novel circulating inflammatory precursors 102
Lower blood levels of isavuconazole in critically ill patients compared with other populations: possible need for therapeutic drug monitoring 102
Short Course of Antifungal Therapy in Patients With Uncomplicated Candida Bloodstream Infection: Another Case of Less Is More in the Clinical Setting? 101
Outcome of early treatment of SARS-CoV-2 infection in patients with haematological disorders 101
Clinical efficacy of eucaloric ketogenic nutrition in the COVID-19 cytokine storm: A retrospective analysis of mortality and intensive care unit admission 99
Una rete multicentrica standardizzata per gestire e analizzare le co-morbidità e gli effetti collaterali legati a terapie HAART in pazienti con infezione da HIV 97
Immunological profile of an infant treated with integrase inhibitor from the neonatal period 97
Higher mortality and intensive care unit admissions in COVID-19 patients with liver enzyme elevations 96
Inflammatory effects of atazanavir/ritonavir versus darunavir/ritonavir in treatment naïve, HIV-1-infected patients 95
1942. Effect of {SARS}-{CoV}-2 Vaccination in a Frailty {COVID}-19 Cohort: a Real Life Experience in a Northern Italy Hospital 94
Healthcare Worker Study Cohort to Determine the Level and Durability of Cellular and Humoral Immune Responses after Two Doses of SARS-CoV-2 Vaccination 94
Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA project 92
Spread of carbapenem-resistant gram-negatives and candida auris during the covid-19 pandemic in critically ill patients: One step back in antimicrobial stewardship? 92
Lipid profile improvement in virologically suppressed hiv-1-infected patients switched to dolutegravir/ abacavir/lamivudine: Data from the SCOLTA project 89
The Longest Persistence of Viable SARS-CoV-2 With Recurrence of Viremia and Relapsing Symptomatic COVID-19 in an Immunocompromised Patient-A Case Study 89
Case report: Sotrovimab, remdesivir and nirmatrelvir/ritonavir combination as salvage treatment option in two immunocompromised patients hospitalized for COVID-19 87
High doses of hydroxychloroquine do not affect viral clearance in patients with SARS-CoV-2 infection 87
Early Clinical Experience with Molnupiravir for Mild to Moderate Breakthrough COVID-19 among Fully Vaccinated Patients at Risk for Disease Progression 85
Neutralizing monoclonal antibodies for the prevention of severe COVID-19: a retrospective study during Omicron BA.1 variant surge 82
Triple combination therapy with two antivirals and monoclonal antibodies for persistent or relapsed SARS-CoV-2 infection in immunocompromised patients 82
Clinical presentation of secondary infectious complications in COVID-19 patients in intensive care unit treated with tocilizumab or standard of care 81
Clinical significance of inflammatory markers of bacterial infection in critically ill patients with COVID-19 after treatment with anti-inflammatory and immunomodulatory drugs: A complex new scenario 81
Behind the screens: Clinical decision support methodologies - A review 80
Prevalence of Viral Hepatitis in Unselected, Consecutively Enrolled Patients Hospitalised for SARS-CoV-2 74
Levels of beta-D-glucan in Candida auris supernatants, an in vitro and in vivo preliminary study 72
Ten Years of Medical Informatics and Standards Support for Clinical Research in an Infectious Diseases Network 70
High prevalence of olfactory and taste disorder during SARS-CoV-2 infection in outpatients 70
Durability of Dolutegravir-Based Regimens: A 5-Year Prospective Observational Study 68
Is a step-down antiretroviral therapy necessary to fight severe acute respiratory syndrome coronavirus 2 in HIV-infected patients? 63
Factors Associated With Weight Gain in People Treated With Dolutegravir 56
Clinical characteristics and outcomes of vaccinated patients hospitalised with SARS-CoV-2 breakthrough infection: Multi-IPV, a multicentre study in Northern Italy 50
Early and Polyantigenic CD4 T Cell Responses Correlate with Mild Disease in Acute COVID-19 Donors 43
West Nile virus: epidemiology, prevention, clinical features, diagnosis, treatment, and open research questions 28
Triple antiviral treatment for COVID-19 in an immunocompromised patient 19
Totale 11.679
Categoria #
all - tutte 42.729
article - articoli 37.401
book - libri 0
conference - conferenze 4.997
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 331
Totale 85.458


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021147 0 0 0 0 0 0 0 0 0 61 36 50
2021/2022789 31 35 38 73 47 46 33 180 70 87 42 107
2022/20231.299 96 134 11 156 147 163 54 86 140 102 187 23
2023/2024832 43 82 16 106 80 171 50 53 34 33 62 102
2024/20252.491 80 146 60 189 251 227 287 501 90 125 286 249
2025/20263.823 555 171 482 317 531 222 570 222 344 409 0 0
Totale 11.679